Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IQVthis companyIQVIA Holdings Inc.	$276.55	28.5×	5.96×	2.38×	18.02×	-24.1%	33.3%	13.4%	8.3%	20.9%	7.9%	5.3%	2.49×	4.83×	2.99×	0.75×	0.0%	8	2.27	3	B
CERTCertara, Inc.	$12.39	-881×	1.33×	3.37×	12.05×	-35.2%	61.5%	5.0%	-0.4%	-0.2%	-0.3%	4.9%	0.01×	-1.74×	1.06×	2.05×	0.0%	7	2.6	2	C+
CRLCharles River Laboratories International, Inc.	$354.08	-69.99×	3.19×	2.51×	31.51×	-76.6%	30.5%	12.6%	-3.6%	-4.6%	8.4%	5.1%	0.97×	6.94×	4.74×	1.29×	0.0%	5	2.99	1	C-
FTREFortrea Holdings Inc.	$22.79	-1.6×	2.79×	0.58×	-3.09×	-197.3%	15.6%	-1.1%	-36.2%	-175.0%	-1.7%	5.6%	1.98×	-1.16×	-0.33×	0.98×	0.0%	5	0.78	1	C-
HCATHealth Catalyst, Inc.	$1.52	-0.94×	0.68×	0.54×	-2.61×	-854.1%	33.5%	-11.6%	-57.2%	-72.4%	-8.6%	-0.1%	0.7×	-1.09×	-2.2×	1.89×	0.0%	5	-6.58	2	C+
MEDPMedpace Holdings, Inc.	$664.41	35.91×	35.29×	6.4×	27.77×	-39.0%	30.1%	21.1%	17.8%	98.3%	67.9%	4.2%	0.3×	-0.63×	0×	0.74×	0.0%	8	8.08	3	B+
Peer median	—	-1.6×	2.79×	2.51×	12.05×	-76.6%	30.5%	5.0%	-3.6%	-4.6%	-0.3%	4.9%	0.7×	-1.09×	0×	1.29×	0.0%	5	2.6	2	—